Haemophilia Research Shifts Focus to Female Experiences: A New Era of Diagnosis and Care
Haemophilia Foundation Australia (HFA) is spearheading a crucial initiative to better understand the healthcare experiences of women and girls living with bleeding disorders. A new survey, launched by the HFA, aims to address a historical gap in research and improve diagnosis, treatment, and overall care for this often-overlooked population.
The Underdiagnosis Challenge in Female Bleeding Disorders
For years, bleeding disorders like haemophilia and von Willebrand disease have been predominantly studied in males. What we have is largely due to the fact that these conditions are X-linked recessive, meaning they primarily manifest in males who have only one X chromosome. Still, females, with two X chromosomes, can also be affected, either as carriers or by experiencing symptoms themselves.
The HFA highlights that approximately 20-30% of females who carry a haemophilia-causing gene mutation experience reduced clotting factor levels, leading to bleeding symptoms and, in some cases, haemophilia. These symptoms can include easy bruising, heavy or prolonged menstrual periods, and prolonged bleeding after medical procedures or injuries.
What the New Survey Aims to Uncover
The HFA survey delves into the challenges women and girls face when advocating for their health in various healthcare settings – from general practitioner visits to emergency department encounters and specialist appointments. It seeks to identify useful tools and resources, such as patient information cards, period diaries, and fact sheets, that can empower patients and their families to navigate the healthcare system more effectively.
Responses will be deidentified and shared with the HFA’s Women and Girls Advisory Group, ensuring the findings directly inform the Foundation’s efforts in representation, education, and research.
Beyond Haemophilia: Expanding the Understanding of Bleeding Disorders
Whereas the survey specifically mentions haemophilia, it’s open to all women and girls with any bleeding disorder, as well as those who are carriers of the gene. This inclusive approach reflects a growing understanding of the diverse range of bleeding disorders and the need for comprehensive research.
The Australian Haemophilia Centre Directors’ Organisation (AHCDO) emphasizes the importance of connecting individuals with bleeding disorders to the HFA, the national peak body representing those affected and their families.
Future Trends: Personalized Medicine and Enhanced Support
This survey represents a shift towards more personalized medicine in the treatment of bleeding disorders. By understanding the specific challenges faced by women and girls, healthcare providers can tailor treatment plans and support services to meet their individual needs.
Expect to see increased development of resources specifically designed for female patients, including improved diagnostic tools for identifying bleeding disorders in women and more effective management strategies for heavy menstrual bleeding and other gender-specific symptoms.
the focus on patient empowerment – through tools like patient cards and period diaries – aligns with a broader trend in healthcare towards shared decision-making and patient-centered care.
FAQ
Q: Who can participate in the survey?
A: Women and girls with bleeding disorders (or who are carriers of the gene), along with their partners or family members who have accompanied them to medical appointments.
Q: What is the deadline for completing the survey?
A: The survey closes at midnight (AEST) on Wednesday, April 8, 2026.
Q: Where can I find more information about the survey?
A: You can contact HFA on 03 9885 7800 or at [email protected].
Q: What is the role of the Women and Girls Advisory Group?
A: The group will analyze the survey results and use them to guide the HFA’s efforts in representation, education, and research.
Q: Where can I learn more about bleeding disorders?
A: Visit the Haemophilia Foundation Australia website at https://www.haemophilia.org.au/ or the National Blood Authority website at https://www.blood.gov.au/clinical-guidance/bleeding-disorders-clinical.
Pro Tip: Preserve a detailed record of your bleeding episodes, including the date, severity, and any associated symptoms. This information can be invaluable when discussing your condition with your healthcare provider.
Have you or a loved one been affected by a bleeding disorder? Share your experiences in the comments below. To stay informed about the latest developments in bleeding disorder research and care, visit the Haemophilia Foundation Australia website.
